FDA: opioid pain meds makers to update prescribing information

The FDA is requiring opioid pain medicine manufacturers to update prescribing information regarding long-term use. Class-wide action will further emphasize and characterize risks of long-term use to help patients, health care professionals make informed treatment decisions.